Related Experiment Video
Updated: Aug 14, 2026
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
Published on: June 4, 2017
Novel therapeutic delivery approaches in development for pediatric gliomas
Abstract:
Pediatric gliomas are a heterogeneous group of diseases, ranging from relatively benign pilocytic astrocytomas with >90% 5-year survival, to glioblastomas and diffuse intrinsic pontine gliomas with <20% 5-year survival. Chemotherapy plays an important role in the management of these tumors, particularly in low-grade gliomas, but many high-grade tumors are resistant to chemotherapy. A major obstacle and contributor to this resistance is the blood–brain barrier, which protects the CNS by limiting entry of potential toxins, including chemotherapeutic agents. Several novel delivery approaches that circumvent the blood–brain barrier have been developed, including some currently in clinical trials. This review describes several of these novel approaches to improve delivery of chemotherapeutic agents to their site of action at the tumor, in attempts to improve their efficacy and the prognosis of children with this disease.
Insights
Novel strategies are exploring ways to overcome the blood-brain barrier, a key challenge in treating pediatric gliomas. These approaches aim to enhance chemotherapy delivery for improved treatment efficacy in children.
Area of Science:
- Neuro-oncology
- Pediatric oncology
- Drug delivery systems
Background:
- Pediatric gliomas exhibit significant heterogeneity, impacting survival rates.
- High-grade pediatric gliomas often display resistance to conventional chemotherapy.
- The blood-brain barrier (BBB) impedes effective drug delivery to the central nervous system (CNS).
Purpose of the Study:
- To review novel therapeutic strategies for pediatric gliomas.
- To explore methods for circumventing the BBB to improve chemotherapy delivery.
- To enhance the efficacy of chemotherapy for improved patient outcomes.
Main Methods:
- Review of current literature on pediatric glioma treatment.
- Analysis of novel drug delivery systems targeting the CNS.
- Examination of approaches designed to overcome the BBB.
Main Results:
- Several novel delivery systems are under investigation.
- These approaches aim to enhance chemotherapeutic agent penetration past the BBB.
- Clinical trials are evaluating the efficacy of these novel strategies.
Conclusions:
- Overcoming the BBB is crucial for effective pediatric glioma treatment.
- Novel delivery methods hold promise for improving chemotherapy efficacy.
- Further research and clinical trials are needed to optimize these approaches for better patient prognosis.
More Related Videos
09:08Author Spotlight: Advancing Glioblastoma Treatment Through Intraarterial Delivery Strategies for Oncolytic Viruses and MicroRNAs
Published on: March 15, 2024
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
